Bases and rationale of the electrochemotherapy

European Journal of Cancer, Supplement - Tập 4 - Trang 38-44 - 2006
L.M. Mir

Tài liệu tham khảo

Miklavcic, 1998, The importance of electric field distribution for effective in vivo electroporation of tissues, Biophys J, 74, 2152, 10.1016/S0006-3495(98)77924-X Miklavcic, 2000, A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy, Biochim Biophys Acta, 1523, 73, 10.1016/S0304-4165(00)00101-X Mir, 1988, Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol, Exp Cell Res, 175, 15, 10.1016/0014-4827(88)90251-0 Orlowski, 1988, Transient electropermeabilization of cells in culture: increase of the cytotoxicity of anticancer drugs, Biochem Pharmacol, 37, 4727, 10.1016/0006-2952(88)90344-9 Mir, 1991, Electrochemotherapy: potentiation of antitumour effect of bleomycin by local electric pulses, Eur J Cancer, 27, 68, 10.1016/0277-5379(91)90064-K Belehradek, 1991, Electrochemotherapy of spontaneous mammary tumours in mice, Eur J Cancer, 27, 73, 10.1016/0277-5379(91)90065-L Mir, 1991, Electrochemotherapy, a new antitumor treatment: first clinical trial, C R Acad Sci III, 313, 613 Belehradek, 1993, Electrochemotherapy, a new antitumor treatment: first clinical phase I-II trial, Cancer, 72, 3694, 10.1002/1097-0142(19931215)72:12<3694::AID-CNCR2820721222>3.0.CO;2-2 Neumann, 1982, Gene transfer into mouse lyoma cells by electroporation in high electric fields, EMBO J, 1, 841, 10.1002/j.1460-2075.1982.tb01257.x Orlowski, 1993, Cell electropermeabilization: a new tool for biochemical and pharmacological studies, Biochim Biophys Acta, 1154, 51, 10.1016/0304-4157(93)90016-H Pucihar, 2006, Numerical determination of transmembrane voltage induced on irregularly shaped cells, Ann Biomed Eng, 34, 642, 10.1007/s10439-005-9076-2 Gehl, 1999, In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution, Biochim Biophys Acta, 1428, 233, 10.1016/S0304-4165(99)00094-X Sersa, 1996, Changing electrode orientation improves the efficacy of electrochemotherapy of solid tumors in mice, Bioelectrochem Bioenerg, 35, 61, 10.1016/0302-4598(95)01866-2 Belehradek, 1994, Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin, Biochim Biophys Acta, 1190, 155, 10.1016/0005-2736(94)90045-0 Weaver, 1996, Theory of electroporation: a review, Bioelectrochem Bioenerg, 41, 135, 10.1016/S0302-4598(96)05062-3 Teissié, 2005, Mechanisms of cell membrane electropermeabilization: a minireview of our present (lack of ?) knowledge, Biochim Biophys Acta, 1724, 270, 10.1016/j.bbagen.2005.05.006 Pucihar, 2002, The effect of pulse repetition frequency on the uptake into electropermeabilized cells in vitro with possible applications in electrochemotherapy, Bioelectrochem, 57, 167, 10.1016/S1567-5394(02)00116-0 Miklavcic, 2005, The effect of high frequency electric pulses on muscle contractions and antitumor efficiency in vivo for a potential use in clinical electrochemotherapy, Bioelectrochemistry, 65, 121, 10.1016/j.bioelechem.2004.07.004 Poddevin, 1991, Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture, Biochem Pharmacol, 42, 67, 10.1016/0006-2952(91)90394-K Mir, 1996, Bleomycin: revival of an old drug, Gen Pharmacol, 27, 745, 10.1016/0306-3623(95)02101-9 Pron, 1993, Identification of a plasma membrane protein that specifically binds bleomycin, Biochem Biophys Res Commun, 194, 333, 10.1006/bbrc.1993.1824 Pron, 1994, Involvement of the membrane bleomycin-binding sites in the bleomycin cytotoxicity, Biochem Pharmacol, 48, 301, 10.1016/0006-2952(94)90101-5 Pron, 1999, Internalisation of the bleomycin molecules responsible for bleomycin toxicity: a receptor-mediated endocytosis mechanism, Biochem Pharmacol, 57, 45, 10.1016/S0006-2952(98)00282-2 Tounekti, 1993, Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized, Cancer Res, 53, 5462 Tounekti, 1995, Relationships between DNA fragmentation, chromatin condensation and changes in flow cytometry profiles detected during apoptosis, Exp Cell Res, 217, 506, 10.1006/excr.1995.1116 Tounekti, 2001, The ratio of single- to double-strand DNA breaks and their absolute values determine cell death pathway, Br J Cancer, 84, 1272, 10.1054/bjoc.2001.1786 Heller, 1998, Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin, Cancer, 83, 148, 10.1002/(SICI)1097-0142(19980701)83:1<148::AID-CNCR20>3.0.CO;2-W Panje, 1998, Electroporation therapy of head and neck cancer, Ann Otol Rhinol Laryngol, 107, 779, 10.1177/000348949810700908 Glass, 1997, Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma, J Am Acad Dermatol, 37, 596, 10.1016/S0190-9622(97)70178-6 Heller, 1997, Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy, Melanoma Res, 7, 10, 10.1097/00008390-199702000-00003 Hyacinthe, 1999, Electrically enhanced drug delivery for the treatment of soft tissue sarcoma, Cancer, 85, 409, 10.1002/(SICI)1097-0142(19990115)85:2<409::AID-CNCR19>3.0.CO;2-I Domenge, 1996, Antitumor electrochemotherapy: new advances in the clinical protocols, Cancer, 77, 956, 10.1002/(SICI)1097-0142(19960301)77:5<956::AID-CNCR23>3.0.CO;2-1 Kubota, 1998, Successful treatment of metastatic skin lesions from bladder cancer by electrochemotherapy, J Urology, 160, 1426, 10.1016/S0022-5347(01)62559-X Kubota, 2005, A case of perineal malignant melanoma successfully treated with electrochemotherapy, Melanoma Res, 15, 133, 10.1097/00008390-200504000-00008 Tada, 1997, Electrochemotherapy significantly inhibits the growth of colon 26 tumors in mice, Surg Today, 27, 506, 10.1007/BF02385803 Sersa, 1995, Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice, Cancer Res, 55, 3450 Cemazar, 1998, Intratumoral cisplatin administration in electrochemotherapy: antitumor effectiveness, sequence dependence and platinum content, Anti-Cancer Drugs, 9, 525, 10.1097/00001813-199807000-00002 Sersa, 2000, Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases, Melanoma Res, 10, 381, 10.1097/00008390-200008000-00010 Sersa, 2000, Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients, Clin Cancer Res, 6, 863 Gehl, 1998, Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs, Anti-Cancer Drugs, 9, 319, 10.1097/00001813-199804000-00005 Jaroszeski, 2000, Toxicity of anticancer agents mediated by electroporation in vitro, Anticancer Drugs, 11, 201, 10.1097/00001813-200003000-00008 Mir, 1992, Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of host’s defenses, Eur Cytokine Netw, 3, 331 Orlowski, 1998, Antimetastatic effects of electrochemotherapy and of histoincompatible interleukin-2 secreting cells in the murine Lewis lung tumor, Anti-Cancer Drugs, 9, 551, 10.1097/00001813-199807000-00006 Mir, 1995, Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2, J Immunother, 17, 30, 10.1097/00002371-199501000-00004 Ramirez, 1998, Electrochemotherapy on liver tumors in rabbits, Br J Cancer, 77, 2104, 10.1038/bjc.1998.354 Heller, 2000, In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity, Melanoma Res, 10, 577, 10.1097/00008390-200012000-00010 Sersa, 1997, Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-α on SA-1 tumors in mice, Cancer Lett, 116, 85, 10.1016/S0304-3835(97)00170-5 Sersa, 1999, Tumor blood flow changes induced by application of electric pulses, Eur J Cancer, 35, 672, 10.1016/S0959-8049(98)00426-2 Gehl, 2002, Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery, Biochim Biophys Acta, 1569, 51, 10.1016/S0304-4165(01)00233-1 Cemazar, 2001, Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy, Br J Cancer, 84, 565, 10.1054/bjoc.2000.1625 Gehl, 2000, Efficient palliation of hemorrhaging malignant melanoma skin metastases by electrochemotherapy, Melanoma Res, 10, 585, 10.1097/00008390-200012000-00011 Davalos, 2005, Tissue ablation with irreversible electroporation, Ann Biomed Eng, 33, 223, 10.1007/s10439-005-8981-8 Edd, 2006, In vivo results of a new focal ablation technique: irreversible electroporation, IEEE Trans Biomed Eng, 53, 1409, 10.1109/TBME.2006.873745 Snoj, 2005, Successful sphincter-saving treatment of anorectal malignant melanoma with electrochemotherapy, local excision and adjuvant brachytherapy, Anticancer Drugs, 16, 345, 10.1097/00001813-200503000-00015 Sersa, 2000, Improvement of combined modality therapy with cisplatin and radiation using electroporation of tumors, Int J Radiat Oncol Biol Phys, 46, 1037, 10.1016/S0360-3016(99)00464-2 Ceberg, 1994, Enhanced boron uptake in RG 2 rat gliomas by electropermeabilization in vivo – a new possibility in boron neutron capture therapy, Anticancer Drugs, 5, 463, 10.1097/00001813-199408000-00012 Cemazar, 2000, Changed delivery of boron to tumors using electroporation for boron neutron capture therapy with BSH, Br J Radiol, 73, 195, 10.1259/bjr.73.866.10884734